---
title: "Imbruvica (ibrutinib), all indications: Dosing and administration questions"
description: "Dosing and administration questions on Imbruvica (ibrutinib) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Administration, Dosing, and Surgery and procedures. Questions: Is there a liquid Imbruvica for patients who have trouble swallowing pills? How should Imbruvica tablets and capsules be taken? What should be done if a dose of Imbruvica is missed? Should Imbruvica be stopped before surgery or dental procedures? 4 questions quoted from 3 sources."
canonical: "https://www.evicenter.com/medical-information/imbruvica/dosing-and-administration"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Imbruvica (ibrutinib), all indications: Dosing and administration questions

Manufacturer: Pharmacyclics LLC; Janssen Biotech, Inc.  
Prescribing information: [Imbruvica](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf)  
Indication pages: [Chronic lymphocytic leukemia and small lymphocytic lymphoma](https://www.evicenter.com/medical-information/imbruvica--chronic-lymphocytic-leukemia-and-small-lymphocytic-lymphoma)

## Administration

<a id="imbruvica-oral-suspension"></a>

### Is there a liquid Imbruvica for patients who have trouble swallowing pills?

> “A formulation option for patients who may have trouble swallowing tablets or capsules.”

Source: [IMBRUVICA: Dosing & Administration - CLL/SLL, captured 2026-11-13](https://www.imbruvicahcp.com/cll/dosing/dosing-and-administration#:~:text=A%20formulation%20option%20for%20patients,trouble%20swallowing%20tablets%20or%20capsules.)

> “Follow Instructions for Use for further administration details of IMBRUVICA oral suspension.”

Source: [IMBRUVICA: Prescribing information, page 3, captured 2026-11-13](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf#page=3)

> “Oral Suspension: 
> 70 mg/mL, white to off-white suspension.”

Source: [IMBRUVICA: Prescribing information, page 7, captured 2026-11-13](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf#page=7)

<a id="imbruvica-how-to-take"></a>

### How should Imbruvica tablets and capsules be taken?

> “Administer IMBRUVICA at approximately the same time each day.  
> Swallow tablets or capsules whole with a glass of water. Do not open, break, or chew the 
> capsules. Do not cut, crush, or chew the tablets. 
> Follow Instructions for Use for further administration details of IMBRUVICA oral suspension.”

Source: [IMBRUVICA: Prescribing information, page 3, captured 2026-11-13](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf#page=3)

## Dosing

<a id="imbruvica-missed-dose"></a>

### What should be done if a dose of Imbruvica is missed?

> “If a dose of IMBRUVICA is not taken at the scheduled time, it can be taken as soon as possible 
> on the same day with a return to the normal schedule the following day. Do not take extra doses 
> of IMBRUVICA to make up for the missed dose.”

Source: [IMBRUVICA: Prescribing information, page 3, captured 2026-11-13](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf#page=3)

## Surgery and procedures

<a id="imbruvica-surgery"></a>

### Should Imbruvica be stopped before surgery or dental procedures?

> “Consider the benefit-risk of withholding IMBRUVICA<sup>®</sup> for at least 3 to 7 days pre- and postsurgery depending upon the type of surgery and the risk of bleeding.”

Source: [IMBRUVICA: Warnings & Precautions - CLL/SLL, captured 2026-11-13](https://www.imbruvicahcp.com/cll/safety/warnings-and-precautions#:~:text=Consider%20the%20benefit%2Drisk%20of%20withholding,and%20the%20risk%20of%20bleeding.)

> “Inform the patient that 
> IMBRUVICA may need to be interrupted for medical or dental procedures [see Warnings and 
> Precautions (5.1)].”

Source: [IMBRUVICA: Prescribing information, page 53, captured 2026-11-13](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf#page=53)

## Related pages
- [Medical information: Imbruvica (ibrutinib): All indications](https://www.evicenter.com/medical-information/imbruvica)
- [Indication](https://www.evicenter.com/medical-information/imbruvica/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/imbruvica/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/imbruvica/safety)
- [Specific populations](https://www.evicenter.com/medical-information/imbruvica/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/imbruvica/drug-interactions)
- [Storage and supply](https://www.evicenter.com/medical-information/imbruvica/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/imbruvica/access-and-coverage)
